Polycystic ovary syndrome is characterized by an increase specifically in LH levels, whereas high levels of FSH are observed in patients or in animal models of ovarian insufficiency (Guigon et al., 2005; Vandormael-Pournin et al., 2015; Malini and Roy George, 2018). Here, BRD2 is linked to polycystic ovary syndrome.